KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Sales (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Return on Sales data on record, last reported at 0.17% in Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.17%; the TTM value through Dec 2025 reached 0.23%, down 37.0%, while the annual FY2025 figure was 0.08%, 22.0% down from the prior year.
  • Return on Sales reached 0.17% in Q4 2025 per JAZZ's latest filing, up from 0.25% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.2% in Q3 2024 and bottomed at 0.69% in Q2 2025.
  • Average Return on Sales over 5 years is 0.01%, with a median of 0.06% recorded in 2022.
  • Peak YoY movement for Return on Sales: surged 52bps in 2022, then plummeted -85bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.04% in 2021, then plummeted by -584bps to 0.25% in 2022, then skyrocketed by 138bps to 0.09% in 2023, then soared by 88bps to 0.18% in 2024, then decreased by -1bps to 0.17% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.17% in Q4 2025, 0.25% in Q3 2025, and 0.69% in Q2 2025.